Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Mecasermin rinfabate

EU orphan designation number: EU/3/06/377
Active ingredient: Mecasermin rinfabate
Indication: Treatment of patients with growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH
Sponsor: Insmed Europe Ltd.
5 Percy Street, Office 4, London W1T 1DG, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/06/2006 Centralised Orphan - Designation EMEA/OD/028/06 (2006)2908 of 20/06/2006
09/11/2006 Other procedure
08/05/2007 Centralised Orphan - Removal of orphan designation from Community Register